Viewing Study NCT02906059


Ignite Creation Date: 2025-12-24 @ 2:56 PM
Ignite Modification Date: 2026-02-18 @ 11:26 PM
Study NCT ID: NCT02906059
Status: COMPLETED
Last Update Posted: 2020-10-12
First Post: 2016-09-09
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Study of Irinotecan and AZD1775, a Selective Wee 1 Inhibitor, in RAS or BRAF Mutated, Second-line Metastatic Colorectal Cancer
Sponsor: NYU Langone Health
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Metastatic Colorectal Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None BRAF View
None Mutated View
None Wee1 inhibitor View
None RAS View
None KRAS View
None NRAS View